As Pim-1 is involved in drug resistance in some cancer types and adjuvant intravesical chemotherapy is one of the most common treatments in bladder cancer, we tested whether Pim-1 is also involved in drug response of bladder cancer cells. Here, PIM1 is linked to cancer.